FDA will monitor 10,000 sites a year to uncover illegal marketing and selling of FDA-regulated products from drugs to tobacco.
10 Space Technologies That Help On Earth
(click image for slideshow)
The Food and Drug Administration plans to monitor the Internet to ensure that prescription drugs, tobacco and other regulated products aren't illicitly traded or marketed online.
In procurement documents posted online March 21, the FDA plans to hire a contractor to look for a laundry list of illegal activity involving FDA-regulated products, from prescription drugs for sale online contrary to U.S. law, to the sale of stolen blood. The monitoring would cover websites that sell products, process payments, perform direct marketing or order fulfillment services, and even in some cases merely provide information online.
The monitoring effort is an outgrowth of the work of the FDA's Office of Criminal Investigation, which investigates a wide array of possible crimes that deal with the distribution of FDA-regulated products, from fraudulent Alzheimer cures to designer drug deals.
According to the procurement documents, the monitoring will include sifting through mounds of publicly available information on websites, online bulletin boards, chat rooms, social networks and even email spam in order to find and report websites that might be engaging in illegal trade or marketing.
Although the FDA will monitor social networks, acting on tips and FDA knowledge and the like, it will not actively participate on any site it monitors as a way to gather more information, the documents said. The contractor might, however, engage in straw purchases online to help the FDA investigate the purchase process and movement of funds in suspected illegal transactions.
Monitoring will be limited to 10,000 websites a year. It's unclear whether this means 10,000 domains, or merely 10,000 discrete websites.
In earlier documents, the FDA said it planned to use the National Cyber-Forensics & Training Alliance as the contractor, saying that the non-profit cyber investigative and data collection organization is the only one with the capabilities to meet the FDA's requirements. The group uses a proprietary database and collaborates with law enforcement and industry to help capture data.
The FDA's monitoring of the Internet for illegal trafficking in regulated substances is only one of the Internet monitoring activities in which the FDA is planning to engage. On another front, the FDA on Saturday awarded a contract to health data collection and analytics company Epidemico to mine social media data to track FDA drug safety efforts.
According to procurement documents, that effort more specifically intends to "assess the usefulness of unstructured social media data mining from a variety of sources in FDA" drug safety efforts, including development of tools and methodologies to make it easier to track health information on social networks.
A well-defended perimeter is only half the battle in securing the government's IT environments. Agencies must also protect their most valuable data. Also in the new, all-digital Secure The Data Center issue of InformationWeek Government: The White House's gun control efforts are at risk of failure because the Bureau of Alcohol, Tobacco, Firearms and Explosives' outdated Firearms Tracing System is in need of an upgrade. (Free registration required.)
The Agile ArchiveWhen it comes to managing data, donít look at backup and archiving systems as burdens and cost centers. A well-designed archive can enhance data protection and restores, ease search and e-discovery efforts, and save money by intelligently moving data from expensive primary storage systems.
2014 Analytics, BI, and Information Management SurveyITís tried for years to simplify data analytics and business intelligence efforts. Have visual analysis tools and Hadoop and NoSQL databases helped? Respondents to our 2014 InformationWeek Analytics, Business Intelligence, and Information Management Survey have a mixed outlook.
InformationWeek Tech Digest, Nov. 10, 2014Just 30% of respondents to our new survey say their companies are very or extremely effective at identifying critical data and analyzing it to make decisions, down from 42% in 2013. What gives?